Ionis Pharmaceuticals, Inc. 13D and 13G filings for AKCEA THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-13 08:47 am Sale |
2020-10-10 | 13D | AKCEA THERAPEUTICS INC AKCA |
IONIS PHARMACEUTICALS INC IONS |
1,000 100.000% |
-77,093,682 (-100.00%) |
Filing |
| 2020-08-31 07:12 am Unchanged |
2020-08-30 | 13D | AKCEA THERAPEUTICS INC AKCA |
IONIS PHARMACEUTICALS INC IONS |
77,094,682 75.900% |
0 (Unchanged) |
Filing |